stella
beta
Multicenter, Platform-type Clinical Study of Refractory/Recurrent Acute Myeloid Leukemia — Stella
Home
/
AML
/
View on ClinicalTrials.gov
Recruiting
Back to AML trials
Not a traditional drug trial — this study doesn't follow the standard phase structure.
Trial locations
(1 site)
China
Blood Hospital, Tianjin